Adjustable wire length stylet handle

ABSTRACT

A stylet-lead assembly including a therapy delivery element and a stylet. The therapy delivery element includes a proximal end with a plurality of electrical contacts adapted to electrically couple with an implantable pulse generator, a distal end with a plurality of electrodes electrically coupled to the electrical contacts, and a lumen having a lumen length extending from the proximal end to almost the distal end. The stylet handle includes a locking insert has a first channel adapted to receive the proximal end of the stylet wire. The portion of the stylet wire extending beyond a proximal end of the locking insert includes at least one bend. A stylet handle has an opening at a distal end adapted to compressively engage the proximal end of the stylet wire to the locking insert, such that an exposed portion of the stylet wire measured from the distal end of the stylet wire to a distal end of the locking insert generally comprises the lumen length.

FIELD

The present disclosure relates to a stylet handle that permits thestylet wire length to be easily adjusted during manufacturing or by thesurgeon.

BACKGROUND

Spinal cord stimulation requires a lead/stylet assembly that has a veryhigh resistance to kinks and high buckling strength since thelead/stylet assembly is pushed through muscle, fascia and other tissue.The lead should preferably have a small diameter profile to facilitateease of insertion into tissue. Because the lead has a small diameter,the stylet wire, by necessity, must also have a small diameter profilein order to fit inside the lead lumen. At the same time, the lead/styletshould preferably offer mechanical characteristics which enable multipleinsertions into tissue, without breaking or permanently bending.Currently several types of lead-stylet assemblies exist for thispurpose. An example of a stylet that engages the proximal end of thelead connector region in specified locations is the Pisces Quad LeadModel 3487A stylet available from Medtronic, Inc., Minneapolis, Minn.,USA.

The location of the distal end of the stylet can potentially reside indifferent locations in the electrode region of the lead due tomanufacturing tolerances in both the lead and the stylet. Manufacturingvariability in the leads often requires the length of the stylet wiresto be custom cut. Since the distal end of the stylet wire is typicallyprepared with a rounded tip that will not damage the lead duringinsertion, the stylet wire needs to be cut at the proximal end.

Stylet handles are typically overmolded onto the stylet wire or two halfpieces are snapped over the stylet wire. These manufacturing techniquesmake it difficult to adjust the length of the stylet wire for differentlengths and tolerances for these therapy delivery elements.

BRIEF SUMMARY

The present disclosure relates to a stylet handle that permits thestylet wire length to be easily adjusted during manufacturing or by thesurgeon.

One embodiment is directed to stylet-lead assembly including a therapydelivery element and a stylet. The therapy delivery element includes aproximal end with a plurality of electrical contacts adapted toelectrically couple with an implantable pulse generator, a distal endwith a plurality of electrodes electrically coupled to the electricalcontacts, and a lumen having a lumen length extending from the proximalend to almost the distal end. The stylet handle includes a lockinginsert having a first channel adapted to receive the proximal end of thestylet wire. The portion of the stylet wire extending beyond theproximal end of the locking insert includes at least one bend. A stylethandle has an opening at a distal end adapted to compressively engagethe proximal end of the stylet wire to the locking insert, such that anexposed portion of the stylet wire measured from the distal end of thestylet wire to a distal end of the locking insert generally comprisesthe lumen length.

In one embodiment the locking insert includes a second channel adaptedto receive a portion of the stylet wire extending beyond the proximalend of the locking insert. The first channel is preferably generallyparallel to the second channel. In another embodiment, the portion ofthe stylet wire extending beyond a proximal end of the locking insertincludes a bend of about 180 degrees located between the first channeland the second channel. The second channel is typically formed in anouter surface of the locking insert.

In another embodiment, the first channel includes a pair of arms adaptedto flex inward to compressively engage the proximate end of the styletwire. The pair of arms preferably includes a cross-sectional areagreater than a cross-sectional area of the opening in the stylet handle.

Another embodiment is directed to an alternate stylet-lead assembly witha stylet handle having a handle lumen extending from a distal end to anopening at a proximal end. The proximal end of the stylet wire extendsthrough the handle lumen and has at least one bend located in theopening. The opening is adapted to compressively engage the stylet wireto the locking insert, such that an exposed portion of the stylet wiremeasured from the distal end of the stylet wire to the distal end of thestylet handle generally comprises the lumen length.

The present disclosure is also directed to a neurostimulation systemincluding an implantable pulse generator. The therapy delivery elementcomprising a proximal end with a plurality of electrical contactsadapted to electrically couple with the implantable pulse generator. Astylet wire with a stylet handle in accordance with the presentdisclosure is located in a lumen in the therapy delivery element.

The present disclosure is also directed to a method of making astylet-lead assembly. The proximal end of a stylet wire is inserted intoa first channel in a locking insert such that an exposed portion of thestylet wire measured from a distal end of the stylet wire to a distalend of the locking insert generally has a length corresponding to alength of a lumen in the therapy delivery element. The portion of thestylet wire extending beyond a proximal end of the locking insert isbent. The portion of the stylet wire extending beyond a proximal end ofthe locking insert is located in a second channel on the locking insert.The proximal end of the locking insert is inserted in an opening in adistal end of a stylet handle. The stylet wire and the locking insertare compressively engaged by the stylet handle. The distal end of thestylet wire is inserted in a lumen accessible at a proximal end of atherapy delivery element.

The present disclosure is also directed to a method of implanting aneurostimulation system within a living body. The method includesgrasping the stylet handle to steer the electrodes at a distal end of atherapy delivery element to a target location within the living body.The stylet is removed from the therapy delivery element. The implantablepulse generator is implanted within the living body. The proximal end ofthe therapy delivery element is electrically coupled with theimplantable pulse generator.

BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING

FIG. 1 is a schematic illustration of a therapy delivery system.

FIG. 2 is a schematic illustration of an environment for a therapydelivery system in accordance with an embodiment of the presentdisclosure.

FIG. 3 is an alternate illustration of the environment for animplantable pulse generator with a therapy delivery element inaccordance with an embodiment of the present disclosure.

FIG. 4A is a schematic illustration of an implantable pulse generatorand a therapy delivery element in accordance with an embodiment of thepresent disclosure.

FIG. 4B is a schematic illustration of a lead extension and a therapydelivery element in accordance with an embodiment of the presentdisclosure.

FIG. 5A is a schematic illustration of a stylet-lead assembly inaccordance with an embodiment of the present disclosure.

FIG. 5B is an exploded view of the stylet-lead assembly of FIG. 5A.

FIGS. 6A-6E are various views of a stylet in accordance with anembodiment of the present disclosure.

FIGS. 7A-7D are various views of a stylet in accordance with anembodiment of the present disclosure.

FIG. 8 is a flow chart of one method of making a stylet in accordancewith an embodiment of the present disclosure.

DETAILED DESCRIPTION OF SOME EMBODIMENTS

The description that follows relates to a spinal cord stimulation (SCS)system. However, it is to be understood that the while the presentdisclosure lends itself well to applications in SCS, the disclosure inits broadest aspects may not be so limited. Rather, the disclosure maybe used with any type of implantable therapy delivery system with one ormore therapy delivery elements. For example, the present disclosure maybe used as part of a pacemaker, a defibrillator, a cochlear stimulator,a retinal stimulator, a stimulator configured to produce coordinatedlimb movement, a cortical stimulator, a deep brain stimulator,peripheral nerve stimulator, microstimulator, or in any other neuralstimulator configured to treat urinary incontinence, sleep apnea,shoulder sublaxation, headache, etc.

In another embodiment, one or more of the therapy delivery elements maybe a fluid delivery conduit, such as a catheter, including an innerlumen that is placed to deliver a fluid, such as pharmaceutical agents,insulin, pain relieving agents, gene therapy agents, or the like from afluid delivery device (e.g., a fluid reservoir and/or pump) to arespective target tissue site in a patient.

In yet another embodiment, one or more of the therapy delivery elementsmay be an electrical lead including one or more sensing electrodes tosense physiological parameters (e.g., blood pressure, temperature,cardiac activity, etc.) at a target tissue site within a patient. In thevarious embodiments contemplated by this disclosure, therapy may includestimulation therapy, sensing or monitoring of one or more physiologicalparameters, fluid delivery, and the like. “Therapy delivery element”includes pacing or defibrillation leads, stimulation leads, sensingleads, fluid delivery conduit, and any combination thereof “Targettissue site” refers generally to the target site for implantation of atherapy delivery element, regardless of the type of therapy.

FIG. 1 illustrates a generalized therapy delivery system 10 that may beused in spinal cord stimulation (SCS), as well as other stimulationapplications. The therapy delivery system 10 generally includes animplantable pulse generator 12 (“IPG”), an implantable therapy deliveryelement 14, which carries an array of electrodes 18 (shown exaggeratedfor purposes of illustration), and an optional implantable extensionlead 16. Although only one therapy delivery element 14 is shown,typically two or more therapy delivery elements 14 are used with thetherapy delivery system 10.

The therapy delivery element 14 includes elongated body 40 having aproximal end 36 and a distal end 44. The elongated body 40 typically hasa diameter of between about 0.03 inches to 0.07 inches and a lengthwithin the range of 30 cm to 90 cm for spinal cord stimulationapplications. The elongated body 40 may be composed of a suitableelectrically insulative material, such as, a polymer (e.g., polyurethaneor silicone), and may be extruded as a uni-body construction.

In the illustrated embodiment, proximal end 36 of the therapy deliveryelement 14 is electrically coupled to distal end 38 of the extensionlead 16 via a connector 20, typically associated with the extension lead16. Proximal end 42 of the extension lead 16 is electrically coupled tothe implantable pulse generator 12 via connector 22 associated withhousing 28. Alternatively, the proximal end 36 of the therapy deliveryelement 14 can be electrically coupled directly to the connector 22.

In the illustrated embodiment, the implantable pulse generator 12includes electronic subassembly 24 (shown schematically), which includescontrol and pulse generation circuitry (not shown) for deliveringelectrical stimulation energy to the electrodes 18 of the therapydelivery element 14 in a controlled manner, and a power supply, such asbattery 26.

The implantable pulse generator 12 provides a programmable stimulationsignal (e.g., in the form of electrical pulses or substantiallycontinuous-time signals) that is delivered to target stimulation sitesby electrodes 18. In applications with more than one therapy deliveryelement 14, the implantable pulse generator 12 may provide the same or adifferent signal to the electrodes 18.

Alternatively, the implantable pulse generator 12 can take the form ofan implantable receiver-stimulator in which the power source forpowering the implanted receiver, as well as control circuitry to commandthe receiver-stimulator, are contained in an external controllerinductively coupled to the receiver-stimulator via an electromagneticlink. In another embodiment, the implantable pulse generator 12 can takethe form of an external trial stimulator (ETS), which has similar pulsegeneration circuitry as an IPG, but differs in that it is anon-implantable device that is used on a trial basis after the therapydelivery element 14 has been implanted and prior to implantation of theIPG, to test the responsiveness of the stimulation that is to beprovided.

The housing 28 is composed of a biocompatible material, such as forexample titanium, and forms a hermetically sealed compartment containingthe electronic subassembly 24 and battery 26 are protected from the bodytissue and fluids. The connector 22 is disposed in a portion of thehousing 28 that is, at least initially, not sealed. The connector 22carries a plurality of contacts that electrically couple with respectiveterminals at proximal ends of the therapy delivery element 14 orextension lead 16. Electrical conductors extend from the connector 22and connect to the electronic subassembly 24.

FIG. 2 illustrates the therapy delivery element 14 implanted in theepidural space 30 of a patient in close proximity to the dura, the outerlayer that surrounds the spinal cord 32, to deliver the intendedtherapeutic effects of spinal cord electrical stimulation. The targetstimulation sites may be anywhere along the spinal cord 32, such as forexample proximate the sacral nerves.

Because of the lack of space near the lead exit point 34 where thetherapy delivery element 14 exits the spinal column, the implantablepulse generator 12 is generally implanted in a surgically-made pocketeither in the abdomen or above the buttocks, such as illustrated in FIG.3. The implantable pulse generator 12 may, of course, also be implantedin other locations of the patient's body. Use of the extension lead 16facilitates locating the implantable pulse generator 12 away from thelead exit point 34. In some embodiments, the extension lead 16 serves asa lead adapter if the proximal end 36 of the therapy delivery element 14is not compatible with the connector 22 of the implantable pulsegenerator 12, since different manufacturers use different connectors atthe ends of their stimulation leads and are not always compatible withthe connector 22.

As illustrated in FIG. 3, the therapy delivery system 10 also mayinclude a clinician programmer 46 and a patient programmer 48. Clinicianprogrammer 46 may be a handheld computing device that permits aclinician to program neurostimulation therapy for patient using inputkeys and a display. For example, using clinician programmer 46, theclinician may specify neurostimulation parameters for use in delivery ofneurostimulation therapy. Clinician programmer 46 supports telemetry(e.g., radio frequency telemetry) with the implantable pulse generator12 to download neurostimulation parameters and, optionally, uploadoperational or physiological data stored by implantable pulse generator12. In this manner, the clinician may periodically interrogate theimplantable pulse generator 12 to evaluate efficacy and, if necessary,modify the stimulation parameters.

Similar to clinician programmer 46, patient programmer 48 may be ahandheld computing device. Patient programmer 48 may also include adisplay and input keys to allow patient to interact with patientprogrammer 48 and the implantable pulse generator 12. The patientprogrammer 48 provides patient with an interface for control ofneurostimulation therapy provided by the implantable pulse generator 12.For example, patient may use patient programmer 48 to start, stop oradjust neurostimulation therapy. In particular, patient programmer 48may permit patient to adjust stimulation parameters such as duration,amplitude, pulse width and pulse rate, within an adjustment rangespecified by the clinician via clinician programmer 46, or select from alibrary of stored stimulation therapy programs.

The implantable pulse generator 12, clinician programmer 46, and patientprogrammer 48 may communicate via cables or a wireless communication.Clinician programmer 46 and patient programmer 48 may, for example,communicate via wireless communication with the implantable pulsegenerator 12 using RF telemetry techniques known in the art. Clinicianprogrammer 46 and patient programmer 48 also may communicate with eachother using any of a variety of local wireless communication techniques,such as RF communication according to the 802.11 or Bluetoothspecification sets, infrared communication, e.g., according to the IrDAstandard, or other standard or proprietary telemetry protocols.

FIG. 3 also illustrates a general environment that may benefit from useof a tunneling tool in accordance with an embodiment of the presentdisclosure. Since the implantable pulse generator 12 is located remotelyfrom target location 50 for therapy, the therapy delivery element 14and/or the extension lead 16 is typically routed through a pathway 52subcutaneously formed along the torso of the patient to a subcutaneouspocket 54 where the implantable pulse generator 12 is located. As usedhereinafter, “lead” and “lead extension” are used interchangeably,unless content clearly dictates otherwise.

The therapy delivery elements 14 are typically fixed in place near thelocation selected by the clinician using the present suture anchors 60.The suture anchors 60 can be positioned on the therapy delivery element14 in a wide variety of locations and orientations to accommodateindividual anatomical differences and the preferences of the clinician.The suture anchors 60 may then be affixed to tissue using fasteners,such as for example, one or more sutures, staples, screws, or otherfixation devices. The tissue to which the suture anchors 60 are affixedmay include subcutaneous fascia layer, bone, or some other type oftissue. Securing the suture anchors 60 to tissue in this manner preventsor reduces the chance that the therapy delivery element 14 will becomedislodged or will migrate in an undesired manner.

FIG. 4A illustrates the therapy delivery element 14 including one ormore electrical contacts 15 at the proximal end 36, and one or moreelectrodes 18 at the distal end 44. The contacts 15 and electrodes 18are electrically coupled via insulated wires running through the therapydelivery element 14. Proximal end 36 of the therapy delivery element 14is electrically and mechanically coupled to implantable pulse generator12 by the connector assembly 22.

The connector assembly 22 includes a plurality of discrete contacts 23located in the housing 28 that electrically couple contact rings 15 onthe proximal end of the therapy delivery element 14. The discretecontacts 23 are electrically coupled to circuitry 24 in the implantablepulse generator 12 by conductive members 21. Each contact ring 15 iselectrically coupled to one or more of the electrodes 18 located at thedistal end 44 of the therapy delivery element 14. Consequently, theimplantable pulse generator 12 can independently deliver electricalimpulses to each of the electrodes 18.

Alternatively, the therapy delivery element 14 can be coupled to theimplantable pulse generator 12 through one or more lead extensions 16,as illustrated in FIG. 4B. The connector 20 at the distal end 38 of thelead extension 16 preferably includes a plurality of the contacts 23configured in a manner similar to the connector assembly 22 (See FIG.4A.

FIGS. 5A and 5B illustrate a stylet/lead assembly 70 including thetherapy delivery element 14 and a stylet 72 in accordance with anembodiment of the present disclosure. The term stylet refers to a toolinserted into the lumen of a therapy delivery element, such as aneurostimulation lead, to stiffen the lead body and to facilitate itsinsertion into a target tissue.

In the illustrated embodiment, stylet 72 includes stylet wire 74attached to handle 76. The stylet wire 74 has a diameter smaller thanlumen 78 in the therapy delivery element 14 and length 80 less thanlength 82 of the lumen 78. The distal end 85 of the therapy deliveryelement is typically sealed, so the length 82 of the lumen 78 is lessthan the length of the therapy delivery element 14. In use, distal end84 of the stylet wire 74 is inserted in lumen 78 of the therapy deliveryelement 14 to create the stylet/lead assembly 70.

Conventional stylet wires for the SCS application are typically made ofstainless steel or tungsten. Tungsten is a malleable, linear elasticmaterial. A stylet wire made from tungsten is flexible and does noteasily break but, unfortunately, has poor kink resistance. “Kinkresistance” refers to the ability of the stylet wire to be bent into arelatively tight bend radius without incurring permanent deformation.

Once a stylet wire 74 kinks, the stylet/lead assembly 70 may have to bewithdrawn from the tissue because the permanent bend in the stylet wire74 makes it difficult to steer the lead/stylet assembly 70 within thetissue. The ability to steer the therapy delivery element 14 is criticalfor achieving optimal stimulation in spinal cord stimulation where apositional difference of a few millimeters may mean the differencebetween poor or effective stimulation. If the stylet wire 74 kinksduring use, both the stylet 72 and therapy delivery element 14 may needto be scrapped because the bent stylet wire 74 cannot be easilyextracted from the lumen 78 without causing further damage to thetherapy delivery element 14 or dislodging the therapy delivery element14 from the tissue site.

Super-elastic materials provide excellent kink resistance but have poorresistance to buckling forces and torque. Consequently, a stylet wire 74made from these materials alone is not be suitable for use for SCStherapy delivery elements. Stylet wires manufactured from combinationsof linear and super-elastic materials have been evaluated, as disclosedin U.S. Pat. Nos. 6,214,016; 6,168,571; 5,238,004; 6,270,496 and5,957,966, which are hereby incorporated by reference.

During manufacturing of the stylet 72, the length 80 of the stylet wire74 needs to be matched with the length 82 of the lumen 78. If the length80 of the stylet wire 74 is greater than the length 82 of the lumen 78,the therapy delivery element 14 is likely to be damaged duringinsertion. Alternatively, if the length 80 of the stylet wire 74 is lessthan the length 82 of the lumen 78, the therapy delivery element 14 willbe difficult to steer into the epidural space 30.

FIGS. 6A-6E illustrate a stylet handle 90 with a locking insert 92 thatcaptures the stylet wire 74 in accordance with an embodiment of thepresent disclosure. The stylet wire 74 is fed in direction 94 throughchannel 96 and out opening 98 at proximal end 100 of the locking insert92 until the exposed length 102 of the stylet wire 74 corresponds to thelength 82 of the lumen 78. The exposed length 102 is measured fromdistal end 84 of the stylet wire 74 to distal end 103 of the lockinginsert 92.

Excess stylet wire 74A protruding beyond opening 98 is bent about 180degrees and located in channel 104 on locking insert 92. In an alternateembodiment, the channel 104 can be formed in the opening 105 in thehandle 90. As best illustrated in FIG. 6E, the stylet handle 90 has anoctagonal cross-section 110 to facilitate gripping of the stylet 112 bythe surgeon.

The proximal end 100 of the locking insert 92 is then inserted inopening 105 of the stylet handle 90. The opening 105 is sized tocompress arms 106A, 106B on the locking insert 92 in direction 108 tolock the stylet wire 74 to the handle 90. The present locking insert 92result in a more controllable manufacturing process than othertechniques.

FIGS. 7A-7D illustrate an alternate stylet handle 120 with a lockinginsert 122 that captures the stylet wire 74 in accordance with anembodiment of the present disclosure. The stylet wire 74 is fed indirection 124 through channel 126 and out opening 128 at proximal end130 of the locking insert 122 until the exposed length 132 of the styletwire 74 corresponds to the length 82 of the lumen 78 plus length 134 ofthe handle lumen 152 in the handle 120. Excess stylet wire 74Aprotruding beyond opening 128 is bent about 180 degrees and located inchannel 136 on locking insert 122.

Distal end 140 of the locking insert 122 is then inserted in opening 142of the stylet handle 120. The opening 140 is sized to compress arms144A, 144B on the locking insert 92 in direction 146 to lock the styletwire 74 to the handle 120. A spacer with length 134 is optionally usedto facilitate manufacturing the stylet 150.

FIG. 8 is a flow diagram of a method of manufacturing a stylet handle inaccordance with an embodiment of the present disclosure. The methodincludes the steps of feeding a stylet wire through a channel in alocking insert (200). The stylet wire is positioned in the lockinginsert so that an exposed length measured from the distal end of thestylet wire to a distal end of the locking insert corresponds to thelength of the lumen in the therapy delivery element (202). Excess styletwire at a proximal end of the locking insert is bent and stored in achannel on locking insert (204). The proximal end of the locking insertis then inserted in an opening in the stylet handle (206). The openingis sized to compress the locking insert to lock the stylet wire to thestylet handle (208).

Where a range of values is provided, it is understood that eachintervening value, to the tenth of the unit of the lower limit unlessthe context clearly dictates otherwise, between the upper and lowerlimit of that range and any other stated or intervening value in thatstated range is encompassed within this disclosure. The upper and lowerlimits of these smaller ranges which may independently be included inthe smaller ranges is also encompassed within the disclosure, subject toany specifically excluded limit in the stated range. Where the statedrange includes one or both of the limits, ranges excluding either bothof those included limits are also included in the disclosure.

Unless defined otherwise, all technical and scientific terms used hereinhave the same meaning as commonly understood by one of ordinary skill inthe art to which this disclosure belongs. Although any methods andmaterials similar or equivalent to those described herein can also beused in the practice or testing of the various methods and materials arenow described. All patents and publications mentioned herein, includingthose cited in the Background of the application, are herebyincorporated by reference to disclose and described the methods and/ormaterials in connection with which the publications are cited.

The publications discussed herein are provided solely for theirdisclosure prior to the filing date of the present application. Nothingherein is to be construed as an admission that the present disclosure isnot entitled to antedate such publication by virtue of prior invention.Further, the dates of publication provided may be different from theactual publication dates which may need to be independently confirmed.

Other embodiments are possible. Although the description above containsmuch specificity, these should not be construed as limiting the scope ofthe disclosure, but as merely providing illustrations of some of thepresently preferred embodiments. It is also contemplated that variouscombinations or sub-combinations of the specific features and aspects ofthe embodiments may be made and still fall within the scope of thisdisclosure. It should be understood that various features and aspects ofthe disclosed embodiments can be combined with or substituted for oneanother in order to form varying modes disclosed. Thus, it is intendedthat the scope of at least some of the present disclosure should not belimited by the particular disclosed embodiments described above.

Thus the scope of this disclosure should be determined by the appendedclaims and their legal equivalents. Therefore, it will be appreciatedthat the scope of the present disclosure fully encompasses otherembodiments which may become obvious to those skilled in the art, andthat the scope of the present disclosure is accordingly to be limited bynothing other than the appended claims, in which reference to an elementin the singular is not intended to mean “one and only one” unlessexplicitly so stated, but rather “one or more.” All structural,chemical, and functional equivalents to the elements of theabove-described preferred embodiment that are known to those of ordinaryskill in the art are expressly incorporated herein by reference and areintended to be encompassed by the present claims. Moreover, it is notnecessary for a device or method to address each and every problemsought to be solved by the present disclosure, for it to be encompassedby the present claims. Furthermore, no element, component, or methodstep in the present disclosure is intended to be dedicated to the publicregardless of whether the element, component, or method step isexplicitly recited in the claims.

1. A stylet-lead assembly comprising: a therapy delivery elementcomprising a proximal end with a plurality of electrical contactsadapted to electrically couple with an implantable pulse generator, adistal end with a plurality of electrodes electrically coupled to theelectrical contacts, and a lumen having a lumen length extending fromthe proximal end to almost the distal end; a stylet wire having aproximal end and a distal end; a locking insert having a first channeladapted to receive the proximal end of the stylet wire, wherein aportion of the stylet wire extending beyond a proximal end of thelocking insert includes at least one bend; and a stylet handle having anopening at a distal end adapted to compressively engage the proximal endof the stylet wire to the locking insert, such that an exposed portionof the stylet wire measured from the distal end of the stylet wire to adistal end of the locking insert generally comprises the lumen length.2. The stylet-lead assembly of claim 1 comprising a second channel inthe locking insert adapted to receive a portion of the stylet wireextending beyond the proximal end of the locking insert.
 3. Thestylet-lead assembly of claim 2 wherein the first channel is generallyparallel to the second channel.
 4. The stylet-lead assembly of claim 2wherein the portion of the stylet wire extending beyond a proximal endof the locking insert includes a bent of about 180 degrees between thefirst channel and the second channel.
 5. The stylet-lead assembly ofclaim 2 wherein the second channel is formed in an outer surface of thelocking insert.
 6. The stylet-lead assembly of claim 1 wherein the firstchannel comprises a pair of arms adapted to flex inward to compressivelyengage the proximate end of the stylet wire.
 7. The stylet-lead assemblyof claim 6 wherein the pair of arms comprise a cross-sectional areagreater than a cross-sectional area of the opening in the stylet handle.8. A stylet-lead assembly comprising: a therapy delivery elementcomprising a proximal end with a plurality of electrical contactsadapted to electrically couple with an implantable pulse generator, adistal end with a plurality of electrodes electrically coupled to theelectrical contacts, and a lumen having a lumen length extending fromthe proximal end to almost the distal end; a stylet wire having aproximal end and a distal end; a locking insert having a first channeladapted to receive the proximal end of the stylet wire, wherein aportion of the stylet wire extending beyond a proximal end of thelocking insert includes at least one bend; and a stylet handle having ahandle lumen extending from a distal end to an opening at a proximalend, the proximal end of the stylet wire extending through the handlelumen with the bend located in the opening, the opening adapted tocompressively engage the stylet wire to the locking insert, such that anexposed portion of the stylet wire measured from the distal end of thestylet wire to the distal end of the stylet handle generally comprisesthe lumen length.
 9. The stylet-lead assembly of claim 8 comprising asecond channel in the locking insert adapted to receive a portion of thestylet wire extending beyond the proximal end of the locking insert. 10.The stylet-lead assembly of claim 9 wherein the first channel isgenerally parallel to the second channel.
 11. The stylet-lead assemblyof claim 9 wherein the portion of the stylet wire extending beyond aproximal end of the locking insert includes a bent of about 180 degreesbetween the first channel and the second channel.
 12. The stylet-leadassembly of claim 8 wherein the first channel comprises a pair of armsadapted to flex inward to compressively engage the proximate end of thestylet wire.
 13. A neurostimulation system comprising: an implantablepulse generator; a therapy delivery element comprising a proximal endwith a plurality of electrical contacts adapted to electrically couplewith the implantable pulse generator, a distal end with a plurality ofelectrodes electrically coupled to the electrical contacts, and a lumenhaving a lumen length extending from the proximal end to almost thedistal end; a stylet wire having a proximal end and a distal end; alocking insert having a first channel adapted to receive the proximalend of the stylet wire, wherein a portion of the stylet wire extendingbeyond a proximal end of the locking insert includes at least one bend;and a stylet handle having an opening at a distal end adapted tocompressively engage the proximal end of the stylet wire to the lockinginsert, such that an exposed portion of the stylet wire measured fromthe distal end of the stylet wire to a distal end of the locking insertgenerally comprises the lumen length.
 14. A neurostimulation systemcomprising: an implantable pulse generator; a therapy delivery elementcomprising a proximal end with a plurality of electrical contactsadapted to electrically couple with the implantable pulse generator, adistal end with a plurality of electrodes electrically coupled to theelectrical contacts, and a lumen having a lumen length extending fromthe proximal end to almost the distal end; a stylet wire having aproximal end and a distal end; a locking insert having a first channeladapted to receive the proximal end of the stylet wire, wherein aportion of the stylet wire extending beyond a proximal end of thelocking insert includes at least one bend; and a stylet handle having ahandle lumen extending from a distal end to an opening at a proximalend, the proximal end of the stylet wire extending through the handlelumen with the bend located in the opening, the opening adapted tocompressively engage the stylet wire to the locking insert, such that anexposed portion of the stylet wire measured from the distal end of thestylet wire to the distal end of the stylet handle generally comprisesthe lumen length.
 15. A method of making a stylet-lead assemblycomprising the steps of: inserting a proximate end of a stylet wire intoa first channel in a locking insert such that an exposed portion of thestylet wire measured from a distal end of the stylet wire to a distalend of the locking insert generally comprises a target length; bending aportion of the stylet wire extending beyond a proximal end of thelocking insert; locating a portion of the stylet wire extending beyond aproximal end of the locking insert in a second channel on the lockinginsert; inserting the proximal end of the locking insert in an openingin a distal end of a stylet handle; compressively engaging the styletwire with the locking insert; and inserting the distal end of the styletwire in a lumen accessible at a proximal end of a therapy deliveryelement, the therapy delivery element comprising a plurality ofelectrical contacts at the proximal end adapted to electrically couplewith an implantable pulse generator, and a distal end with a pluralityof electrodes electrically coupled to the electrical contacts.
 16. Amethod of implanting a neurostimulation system within a living body, themethod comprising the steps of: grasping the stylet handle of claim 15to steer the electrodes at a distal end of a therapy delivery element toa target location within the living body; removing the stylet from thetherapy delivery element; implanting the implantable pulse generatorwithin the living body; and electrically coupling the electricalcontacts at the proximal end of the therapy delivery element with theimplantable pulse generator.